Cannabis Science Inc. To Oversee Research For NewColombia Resources

Publishing & Media

Share Tweet

Cannabis Science Inc. To Oversee Research For NewColombia Resources

Cannabis Science Inc. (OTCQB: CBIS) saw its share volume cut in half on May 20th with 5,662,881 shares exchanging hands compared to its three month daily average volume of 10,912,873 shares.

Just last week, it was announced that NewColombia Resources is in discussions with Cannabis Science, Inc. to oversee research in Colombia once protocols are established by Farmatech S.A., a pharmaceutical laboratory that collaborates with private companies, universities, NGOs, and institutions.  Farmatech in an agreement with New Colombia for the research and development of topical cannabis based medicines to treat skin cancer and other ailments in Colombia. 

Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate.

The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions.

CBIS closed the day at $.07 on May 20th. is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:


Vega Biofuels, Inc. Sees Drop In Share Volume

Vega Biofuels, Inc. (OTCPINK: VGPR) saw its share volume drop on May 20th with 38,984,036 shares exchanging hands, significantly lower than its three month daily average of 74,677,580 shares.

Just last week, Vega Biofuels, Inc. announced that it is in the process of acquiring one hundred percent of a six year old Colorado export business that will become the Company's international export arm to meet the tremendous demand for its biochar product in Latin America.

Vega recently announced it has acquired the Legal Hemp and Marijuana Division of Colorado based Biochar Now, LLC.  "This is a major step for our Company," stated Michael K. Molen, Chairman/CEO of Vega Biofuels. "Once orders started coming in from Latin America, we felt that it was critical to our long term business strategy to involve individuals that specialize in doing business in that part of the world. The largest order to date is coming from Ecuador. The amount of biochar that will be shipped to that country is greater than the entire amount of product that we have sold so far. We are continuing to receive a lot of attention from hemp and marijuana growers in Colorado as well as Washington. "

Michael K. Molen, continued to state, "There is a tremendous amount of agricultural business throughout Latin America and we plan to market heavily in that part of the world. This acquisition will expedite that process. We will have details concerning the acquisition in the next few days. I also want to thank our shareholders for their continued patience and support during this process."

VGPR closed at $.0098 on May 20th. is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:


Franceen Reeves Appointed MediJane Holdings Inc.’s Head of Sales For California

MediJane Holdings Inc. (OTCQB: MJMD) saw its share volume soar on May 20th with 436,471 shares exchanging hands, much higher than its three month daily average volume of 112,262 shares.  While this uptick in share volume occurred, its share price dropped 28.71% from $1.01 to $.72.

On Friday, MediJane Holdings Inc. announced that it has successfully concluded a recruitment process and has appointed Franceen Reeves as MediJane's new Head of Sales for the state of California.

"Ms. Reeves' vast clinical and practical medical experience, personnel & resource management, and hands-on sales skills makes her an ideal candidate for the position of MediJane Head of Sales for California," commented Ronald Lusk, CEO of MediJane Holdings Inc. "Her being a proud patriot and military veteran also assisted me in the decision to add Franceen to the MediJane team." is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:


ABOUT US: issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:



Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.